Alger Small Cap Growth Fund Q1 2025 Commentary
This article was written by Follow Fred Alger Management, LLC (“Alger”) is a privately held $27.4 billion growth equity investment manager. Alger is a
SSE plc (SSEZF) Q4 2025 Earnings Call Transcript
SSE plc (OTCPK:SSEZF) Q4 2025 Earnings Conference Call May 21, 2025 5:00 PM ET Company Participants Alistair Phillips-Davies – Chief Executive OfficerBarry O’Regan –
Lazard U.S. Convertibles Portfolio Q1 2025 Commentary
This article was written by Follow Lazard Asset Management delivers world-class investment solutions and long-term value for their clients. When clients partner with Lazard,
ConnectOne – Don’t Bank On The First National Deal (NASDAQ:CNOB)
This article was written by Follow The author has an honours degree in economics and politics with a focus on economic development. With 36
Datavault AI Inc. (DVLT) Investor Conference Call (Transcript)
Datavault AI Inc. (NASDAQ:DVLT) Investor Conference Call May 20, 2025 9:00 AM ET Company Participants David Barnard – IR, Alliance Advisors Investor RelationsNate Bradley
Student loan delinquencies tank credit scores for millions of borrowers: How to recover
A 100-point drop in a credit score can be “absolutely catastrophic.” It can also take years to recover from, according to LendingTree chief credit
Travel experts break down the top credit cards to maximize summer vacation savings
The busy summer travel season will soon get underway at a time when consumer wallets continue to be stretched. Spending on the right credit
Engie SA (ENGIY) Q1 2025 Earnings Call Transcript
Engie SA (OTCPK:ENGIY) Q1 2025 Results Conference Call May 15, 2025 4:00 AM ET Company Participants Delphine Deshayes – Investor RelationsCatherine MacGregor – Chief
Student loan delinquencies surge, sending credit scores plunging for borrowers
A new report from the New York Federal Reserve found that while Americans’ credit card debt is falling, an uptick in student loan delinquencies is
Ideaya Biosciences: Value Beyond Darovasertib With ADC Program IDE849 (NASDAQ:IDYA)
This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science
Most Read
